Ó³»­´«Ã½

The effort will engage with patients, empowering them to share their unique health data with scientists to accelerate research.

Researchers find four coordinated gene expression programs in immune cells from glioma tumors, including two that could lead to immunotherapy resistance.

Targeting the PELO gene could be a way to kill tumor cells in cancers with one of two common genetic mutations.

Wolu Chukwu talks about how she brings a community-first focus to her work in cancer genetics. 

Slow-growing glioma tumors become more aggressive when their cells shift identities and acquire new genetic mutations.

Ó³»­´«Ã½ and Mass General researcher Alexandra-Chloé Villani and Mass General oncologist Kerry Reynolds describe their pioneering effort to better understand, diagnose, and manage dangerous complications from cancer immunotherapy. 

Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.

The team compared different single-cell and spatial profiling methods to explore the diversity of cells in metastatic breast cancer biopsies.

BRD-810 inhibits the MCL1 protein and reactivates apoptosis in tumor cells, displaying therapeutic potential in animal models.

New study shows how leveraging unsupervised learning can decode DCIS progression from chromatin images.